Cargando…

Immunogenicity of rotavirus vaccine (Rotarix(TM)) in infants with environmental enteric dysfunction

INTRODUCTION: Deployment of rotavirus vaccines has contributed to significant declines in diarrheal morbidity and mortality globally. Unfortunately, vaccine performance in low-middle income countries (LMICs) is generally lower than in developed countries. The cause for this has been associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mwape, Innocent, Bosomprah, Samuel, Mwaba, John, Mwila-Kazimbaya, Katayi, Laban, Natasha Makabilo, Chisenga, Caroline Cleopatra, Sijumbila, Gibson, Simuyandi, Michelo, Chilengi, Roma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744930/ https://www.ncbi.nlm.nih.gov/pubmed/29281659 http://dx.doi.org/10.1371/journal.pone.0187761

Ejemplares similares

Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia
por: Mwila-Kazimbaya, Katayi, et al.
Publicado: (2017)

Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (Rotarix(TM)) Immunogenicity among Infants in Zambia
por: Chauwa, Adriace, et al.
Publicado: (2023)

In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine
por: Kazimbaya, Katayi Mwila, et al.
Publicado: (2020)

Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach
por: Mwila-Kazimbaya, Katayi, et al.
Publicado: (2023)

Evaluation of ROTARIX(®) Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial
por: Laban, Natasha Makabilo, et al.
Publicado: (2023)

T-Cell Responses after Rotavirus Infection or Vaccination in Children: A Systematic Review
por: Laban, Natasha Makabilo, et al.
Publicado: (2022)

Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants
por: Chilengi, Roma, et al.
Publicado: (2016)

Nutritional status, environmental enteric dysfunction, and prevalence of rotavirus diarrhoea among children in Zambia
por: Koyuncu, Aybüke, et al.
Publicado: (2020)

Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study
por: Chisenga, Caroline C., et al.
Publicado: (2021)

Early linear growth retardation: results of a prospective study of Zambian infants
por: Chilengi, Roma, et al.
Publicado: (2019)

Assessment of the influence of ABO blood groups on oral cholera vaccine immunogenicity in a cholera endemic area in Zambia
por: Chisenga, Caroline C., et al.
Publicado: (2023)

Effect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia
por: Luchen, Charlie Chaluma, et al.
Publicado: (2021)

Superimposed Pulmonary Tuberculosis (PTB) in a 26-Year-Old Female with No Underlying Co-Morbidities Recovering from COVID-19—Case Report
por: Njekwa, Katanekwa, et al.
Publicado: (2023)

Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol(™)) in adults residing in Lukanga Swamps of Zambia
por: Ng′ombe, Harriet, et al.
Publicado: (2022)

Three transmission events of Vibrio cholerae O1 into Lusaka, Zambia
por: Mwaba, John, et al.
Publicado: (2021)

Comparing growth velocity of HIV exposed and non-exposed infants: An observational study of infants enrolled in a randomized control trial in Zambia
por: Chilyabanyama, Obvious Nchimunya, et al.
Publicado: (2021)

Clinical presentation of congenital syphilis in a rotavirus vaccine cohort study in Lusaka: a case series
por: Sukwa, Nsofwa, et al.
Publicado: (2021)

Performance of Machine Learning Classifiers in Classifying Stunting among Under-Five Children in Zambia
por: Chilyabanyama, Obvious Nchimunya, et al.
Publicado: (2022)

Sensitivity and predictive value of dysentery in diagnosing shigellosis among under five children in Zambia
por: Miti, Sam, et al.
Publicado: (2023)

Prevalence of Diarrhoeagenic Escherichia coli among Children Aged between 0–36 Months in Peri-Urban Areas of Lusaka
por: Mwape, Kapambwe, et al.
Publicado: (2023)

Use of an ETEC Proteome Microarray to Evaluate Cross-Reactivity of ETVAX(®) Vaccine-Induced IgG Antibodies in Zambian Children
por: Mubanga, Cynthia, et al.
Publicado: (2023)

Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review
por: Luchen, Charlie C., et al.
Publicado: (2023)

Identification of cholera hotspots in Zambia: A spatiotemporal analysis of cholera data from 2008 to 2017
por: Mwaba, John, et al.
Publicado: (2020)

Health care workers' reactions to the newly introduced hepatitis B vaccine in Kalulushi, Zambia: Explained using the 5A taxonomy
por: Nyasa, Mwiza, et al.
Publicado: (2023)

Norovirus infections in young children in Lusaka Province, Zambia: clinical characteristics and molecular epidemiology
por: Howard, Leigh M., et al.
Publicado: (2017)

Epstein–Barr Virus Detection in the Central Nervous System of HIV-Infected Patients
por: Musukuma-Chifulo, Kalo, et al.
Publicado: (2022)

Field evaluation of a novel, rapid diagnostic assay, and molecular epidemiology of enterotoxigenic E. coli among Zambian children presenting with diarrhea
por: Silwamba, Suwilanji, et al.
Publicado: (2022)

Pharmacoeconomic Spotlight on Rotavirus Vaccine RIX4414 (Rotarix™) in Developed Countries
por: Plosker, Greg L.
Publicado: (2012)

The human rotavirus vaccine Rotarix™ in infants: An integrated analysis of safety and reactogenicity
por: Buyse, Hubert, et al.
Publicado: (2014)

Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC
por: Debellut, Frédéric, et al.
Publicado: (2020)

Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants
por: Chilengi, R., et al.
Publicado: (2021)

Development of a diarrhoea severity scoring scale in a passive health facility-based surveillance system
por: St Jean, Denise T., et al.
Publicado: (2022)

Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial
por: Steele, Andrew Duncan, et al.
Publicado: (2012)

The evolving epidemiology of rotavirus A infection in Brazil a decade after the introduction of universal vaccination with Rotarix®
por: Carvalho-Costa, Filipe A., et al.
Publicado: (2019)

Rotarix in Japan: Expectations and Concerns
por: Nakagomi, Osamu, et al.
Publicado: (2011)

Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception
por: Singh, Tina, et al.
Publicado: (2022)

Ecological Niche Modeling of Aedes and Culex Mosquitoes: A Risk Map for Chikungunya and West Nile Viruses in Zambia
por: Velu, Rachel Milomba, et al.
Publicado: (2023)

Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: A post-marketing surveillance study
por: Bravo, Lulu, et al.
Publicado: (2014)

Post-marketing safety surveillance conducted in Korea (2008–2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™)
por: Shin, Son Moon, et al.
Publicado: (2016)

Correction to: Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception
por: Singh, Tina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aab82cfn07kc5ou9pmkjbn2mh4